Coya Therapeutics, Inc. financial data

Symbol
COYA on Nasdaq
Location
12645 Memorial Dr., Suite F1 #305, Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.01K % +16.5%
Debt-to-equity 13.9 % -8.08%
Return On Equity -61.1 % -71.3%
Return On Assets -53.6 % -73.2%
Operating Margin -5.34K % -4776%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.7M shares +9.88%
Common Stock, Shares, Outstanding 16.7M shares +9.88%
Entity Public Float 85.2M USD +134%
Common Stock, Value, Issued 1.67K USD +9.85%
Weighted Average Number of Shares Outstanding, Basic 16.7M shares +12.1%
Weighted Average Number of Shares Outstanding, Diluted 16.7M shares +12.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 423K USD -95.6%
General and Administrative Expense 9.98M USD +12.5%
Operating Income (Loss) -22.6M USD -116%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.09M USD -111%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -20.3M USD -101%
Earnings Per Share, Basic -1 USD/shares -67.6%
Earnings Per Share, Diluted -1 USD/shares -67.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.8M USD -18.6%
Assets, Current 33.4M USD -16.2%
Property, Plant and Equipment, Net 24.9K USD -52.3%
Assets 33.5M USD -16.2%
Accounts Payable, Current 931K USD -50.5%
Accrued Liabilities, Current 2.84M USD +183%
Liabilities, Current 4.5M USD +17.7%
Liabilities 5.14M USD +9.83%
Retained Earnings (Accumulated Deficit) -54.1M USD -60.2%
Stockholders' Equity Attributable to Parent 28.3M USD -19.7%
Liabilities and Equity 33.5M USD -16.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.83M USD -232%
Net Cash Provided by (Used in) Financing Activities 19.1K USD -98.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 16.7M shares +9.88%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 8.13M USD +44.5%
Depreciation 27.4K USD 0%
Property, Plant and Equipment, Gross 137K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.35M USD +208%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 82.4M USD +19.4%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.68M USD +130%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%